Generative network models of altered structural brain connectivity in schizophrenia.

NeuroImage
Xiaolong ZhangHeike Tost

Abstract

Alterations in the structural connectome of schizophrenia patients have been widely characterized, but the mechanisms remain largely unknown. Generative network models have recently been introduced as a tool to test the biological underpinnings of altered brain network formation. We evaluated different generative network models in healthy controls (n=152), schizophrenia patients (n=66), and their unaffected first-degree relatives (n=32), and we identified spatial and topological factors contributing to network formation. We further investigated how these factors relate to cognition and to polygenic risk for schizophrenia. Our data show that among the four tested classes of generative network models, structural brain networks were optimally accounted for by a two-factor model combining spatial constraints and topological neighborhood structure. The same wiring model explained brain network formation across study groups. However, relatives and schizophrenia patients exhibited significantly lower spatial constraints and lower topological facilitation compared to healthy controls. Further exploratory analyses point to potential associations of the model parameter reflecting spatial constraints with the polygenic risk for schizophre...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Feb 19, 1998·Schizophrenia Research·T J Crow
May 4, 2002·Neuron·Dmitri B ChklovskiiCharles F Stevens
Oct 23, 2002·Human Brain Mapping·Stephen M Smith
Dec 10, 2003·Archives of General Psychiatry·Patrick F SullivanMichael C Neale
Mar 30, 2004·Trends in Neurosciences·György BuzsákiXiao-Jing Wang
Jun 26, 2004·Annual Review of Neuroscience·Dmitri B Chklovskii, Alexei A Koulakov
Aug 31, 2004·Neural Computation·Dmitri B Chklovskii
Apr 6, 2007·BMC Systems Biology·Luciano da F CostaClaus C Hilgetag
May 18, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sharon L Eastwood, Paul J Harrison
Feb 27, 2008·Brain : a Journal of Neurology·Yong LiuTianzi Jiang
Sep 12, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Danielle S BassettAndreas Meyer-Lindenberg
May 6, 2009·Neuropsychology·Raquelle I Mesholam-GatelyLarry J Seidman
Aug 25, 2009·Lancet·Jim van Os, Shitij Kapur
Jul 16, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mary-Ellen LynallEd Bullmore
Oct 30, 2010·Frontiers in Systems Neuroscience·Aaron F Alexander-BlochEdward T Bullmore
Nov 26, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Martijn P van den HeuvelHilleke E Hulshoff Pol
Dec 7, 2010·Annual Review of Clinical Psychology·Edward T Bullmore, Danielle S Bassett
Dec 21, 2010·American Journal of Human Genetics·Jian YangPeter M Visscher
Jan 22, 2011·PLoS Computational Biology·Sreedevi Varier, Marcus Kaiser
Mar 8, 2011·Current Opinion in Genetics & Development·Roberta Rasetti, Daniel R Weinberger
Aug 4, 2011·Archives of General Psychiatry·Roberta RasettiDaniel R Weinberger
Dec 16, 2011·Trends in Cognitive Sciences·Deanna M Barch, Alan Ceaser
Mar 6, 2012·NeuroImage·Alex FornitoEdward T Bullmore
Apr 3, 2012·Proceedings of the National Academy of Sciences of the United States of America·Petra E VértesEdward T Bullmore
Apr 14, 2012·Nature Reviews. Neuroscience·Ed Bullmore, Olaf Sporns
Jul 11, 2012·Nature Reviews. Genetics·Patrick F SullivanMichael O'Donovan
Sep 22, 2012·Journal of Neurotrauma·Harvey S LevinPaul Swank
Dec 28, 2012·Nature Methods·Olivier DelaneauJonathan Marchini
Jan 18, 2013·Current Opinion in Psychiatry·Jennifer FitzsimmonsMartha E Shenton
Apr 5, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Carsten GiessingEdward T Bullmore
Jun 7, 2013·JAMA Psychiatry·Martijn P van den HeuvelRené S Kahn
Sep 17, 2013·PloS One·Thomas P K BreckelCarsten Giessing
Dec 19, 2013·PloS One·Fang-Cheng YehWen-Yih Isaac Tseng
Feb 7, 2014·Neuropsychology Review·Martijn P van den Heuvel, Alex Fornito
Apr 5, 2014·PLoS Computational Biology·David SamuThomas Nowotny
Apr 12, 2014·Frontiers in Neuroanatomy·Michel A Hofman
Jul 25, 2014·Nature·UNKNOWN Schizophrenia Working Group of the Psychiatric Genomics Consortium
Jul 27, 2014·Brain Structure & Function·Sarah F BeulClaus C Hilgetag

❮ Previous
Next ❯

Citations

Jul 11, 2021·Nature Communications·Danyal AkarcaDuncan E Astle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.